Role of DHEA in cardiovascular diseases
Authors:
- Jean-Pierre SavineauJSJean-Pierre Savineau
- Roger MarthanRMRoger Marthan
- Eric Dumas de la RoqueEREric Dumas de la Roque
- 1 March 2013
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 85 (6) , 718-726
Abstract
No abstract availableKeywords
Funding Information
- Fondation de France (2008002719)
- Conseil Régional d’Aquitaine (20111302006)
This publication has 116 references indexed in Scilit:
- Physiological effects of androgens on human vascular endothelial and smooth muscle cells in cultureSteroids, 2011
- Dehydroepiandrosterone protects against oxidative stress‐induced endothelial dysfunction in ovariectomized ratsThe Journal of Physiology, 2011
- Signal Transducers and Activators of Transcription-3/Pim1 Axis Plays a Critical Role in the Pathogenesis of Human Pulmonary Arterial HypertensionCirculation, 2011
- Cellular and Molecular Basis of Pulmonary Arterial HypertensionJACC, 2009
- Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertensionBritish Journal of Pharmacology, 2008
- Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosteroneAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertensionCardiovascular Research, 2007
- Regulation of the nuclear export of the transcription factor NFATc1 by protein kinases after slow fibre type electrical stimulation of adult mouse skeletal muscle fibresThe Journal of Physiology, 2007
- Cigarette Smoking and Levels of Adrenal Androgens in Postmenopausal WomenNew England Journal of Medicine, 1988
- A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular DiseaseNew England Journal of Medicine, 1986